Viewing nowDaehwa Levamisole Extended-release Tablet 150 mg
Rebamipide 150mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 202600121 · Approved 2026.01.14
Treatment of acute and chronic gastritis exacerbation through improvement of gastric mucosal lesions (erosions, bleeding, etc.)
This medication is used to improve gastric mucosal lesions such as erosion, bleeding, erythema, and edema that occur during the acute exacerbation of acute and chronic gastritis.
Adults should take 1 tablet twice a day, once in the morning and once in the evening. This medication should be swallowed whole and should not be divided or chewed.
This medication must not be given to patients who are hypersensitive to any of its components. While taking this medication, caution should be taken as gastrointestinal symptoms, infections, and myalgia may occur as side effects. Reported side effects in clinical trials are primarily mild gastrointestinal disturbances, and serious adverse reactions are rare. Severe allergic reactions such as shock or anaphylaxis may rarely occur, so if any symptoms appear, immediately stop taking the medication and consult a healthcare professional. Abnormal liver function or hematological abnormalities may also occur, so it is important to regularly monitor your condition during treatment. Women who are pregnant or may become pregnant should be cautious when taking this medication, and it is advisable to avoid breastfeeding while on this medication. Safety in children and adolescents has not been sufficiently established, so caution is required for use. Elderly patients may have weakened bodily functions and should be particularly cautious about side effects such as gastrointestinal symptoms. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may degrade the quality of the medication.
Severe allergic reactions (shock, anaphylaxis-like symptoms, urticaria, severe swelling), hematological abnormalities (leukopenia, thrombocytopenia), liver abnormalities (liver dysfunction, jaundice), serious neurological symptoms (paralysis)
Gastrointestinal disturbances (nausea, dyspepsia, constipation, abdominal bloating, diarrhea, epigastric pain, etc.), infections and infestations (nasopharyngitis, tonsillitis, epididymitis), musculoskeletal and connective tissue disorders (myalgia, arthralgia, muscle weakness), neurological disorders (dizziness, headache, migraine, drowsiness), skin and subcutaneous tissue disorders (dry skin, eczema, pruritus, rash, itching, drug-induced eczema), mental disorders (depression, insomnia), respiratory issues
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C. It is safe to avoid extremely hot or cold places.
White rectangular extended-release tablet
Bottle packaging - 30 tablets/bottle, bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 150mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.